Article Text

Download PDFPDF
Response to ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’’ by Montero et al
  1. Alessandro Tomelleri1,2,
  2. Lorenzo Dagna1,2,
  3. Corrado Campochiaro1,2
  1. 1 Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Hospital, Milan, Italy
  2. 2 Vita-Salute San Raffaele University, Milan, Italy
  1. Correspondence to Dr Corrado Campochiaro, Università Vita-Salute San Raffaele, School of Medicine; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Hospital, Milano, 20132 MI, Italy; campochiaro.corrado{at}hsr.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the correspondence by Montero et al 1 on our study about the impact of novel COVID-19 on Italian patients with large vessel vasculitis.2 First of all, we thank the authors for the positive appraisal of our study and for providing their original contribution, which certainly enhances our knowledge of the influence that the COVID-19 pandemic had, and is still having, on patients affected by giant cell arteritis (GCA).

The authors performed a comparative study evaluating the rate of referral to their ultrasound fast-track clinic (FTC) in Madrid before and during the first 8 months of the pandemic (July 2019–February 2020 and March 2020–October 2020). Interestingly, since the COVID-19 outbreak, they observed a 38% reduction in GCA FTC referrals, …

View Full Text

Footnotes

  • Handling editor Josef S Smolen

  • Contributors AT, LD and CC wrote the manuscript and critically revised the data.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles